The team, led by Professor Navin Varadarajan, developed NanoSTING, a nasal spray that activates the ... individuals and ...

Researchers at Brigham and Women’s Hospital have developed a nasal spray that could provide broad-spectrum protection against ...

First, existing COVID-19 vaccines provide robust protection against severe ... Nasal vaccination has had a long but mixed history. In Russia, a nasal spray against influenza has been in use since 1987 ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract allows for robust antibody and T-cell responses where SARS-CoV-2 generally ...

On March 10, the Department of Justice (DOJ) moved to drop a lawsuit filed on behalf of the Federal Trade Commission (FTC) against Xlear, ...

According to a research, two Australian respiratory scientists are looking to develop a nasal spray for Covid-19 vaccination. Professor Daniela Traini from Macquarie University and Professor Pall ...

Xlear says the move calls FTC’s authority to require clinical studies for non-pharmaceutical health products into question.

Emergent BioSolutions is investing in Swiss biotech Rocketvax, inking a deal designed to fuel the preclinical company’s R&D.

A recent study has found an over-the-counter nasal spray may interfere with respiratory virus diagnostic swabs. Northern ...